The new drug application is supported by 48-week data from the Phase III MK-8591A-051 and MK-8591A-052 trials, which showed ...

Today, despite there being 55 individual and combination drugs available to treat HIV and AIDS, 9 32 million people have died of HIV and 37.9 million were living with the disease at the end of ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

The Basics: HIV and Heart Disease. You’re more likely to have heart disease if you have the human immunodeficiency virus (), which causes AIDS.Some research suggests that inflammation caused by ...

The Aptima HIV-1 Quant Dx assay, which was approved in late 2016 for viral load monitoring, is a molecular diagnostic test that runs on the fully automated, sample-to-result Panther® system.

The death toll from HIV/AIDS continues to decline, but more than 36 million people are still living with HIV. A researcher explains why the work for a cure is painstaking.

The future of HIV prevention research depends on all of us working together. Most importantly, it depends on the understanding, trust, support, and participation of all communities. Learn more about ...

A twice-yearly injection to prevent HIV could dramatically alter the course of an epidemic that has lead to the deaths of more than 40 million people since the 1980s. Here's what to know.

Nature - Back to basics for HIV vaccine development. The US programme to develop an HIV vaccine will shift funding back towards basic research and away from clinical trials of candidate vaccines ...

HIV Life Cycle Basics. Efforts to devise vaccines and treatments for HIV depend on knowledge of the virus's life cycle. Join Our Community of Science Lovers! Sign Up for Our Free Daily Newsletter.